Power Approaches for Implantable Medical Devices. by Ben Amar, Achraf et al.
UC Irvine
UC Irvine Previously Published Works
Title
Power Approaches for Implantable Medical Devices.
Permalink
https://escholarship.org/uc/item/8vt781zc
Journal
Sensors (Basel, Switzerland), 15(11)
ISSN
1424-8220
Authors
Ben Amar, Achraf
Kouki, Ammar B
Cao, Hung
Publication Date
2015-11-13
DOI
10.3390/s151128889
License
CC BY 4.0
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Sensors 2015, 15, 28889-28914; doi:10.3390/s151128889 
 
sensors 
ISSN 1424-8220 
www.mdpi.com/journal/sensors 
Review 
Power Approaches for Implantable Medical Devices 
Achraf Ben Amar 1,*, Ammar B. Kouki 1 and Hung Cao 2 
1 LACIME Laboratory, University of Quebec, ÉTS, 1100 Notre-Dame West, Montreal,  
QC H3C 1K3, Canada; E-Mail: ammar.kouki@etsmtl.ca 
2 Division of Engineering, STEM, University of Washington, Bothell, WA 98011, USA;  
E-Mail: hungcao@uw.edu 
* Author to whom correspondence should be addressed; E-Mail: achraf.ben.amar@lacime.etsmtl.ca;  
Tel.: +1-514-473-8416.  
Academic Editor: Alexander Star 
Received: 30 August 2015 / Accepted: 6 November 2015 / Published: 13 November 2015 
 
Abstract: Implantable medical devices have been implemented to provide treatment and to 
assess in vivo physiological information in humans as well as animal models for medical 
diagnosis and prognosis, therapeutic applications and biological science studies. The advances 
of micro/nanotechnology dovetailed with novel biomaterials have further enhanced 
biocompatibility, sensitivity, longevity and reliability in newly-emerged low-cost and compact 
devices. Close-loop systems with both sensing and treatment functions have also been 
developed to provide point-of-care and personalized medicine. Nevertheless, one of the 
remaining challenges is whether power can be supplied sufficiently and continuously for the 
operation of the entire system. This issue is becoming more and more critical to the increasing 
need of power for wireless communication in implanted devices towards the future healthcare 
infrastructure, namely mobile health (m-Health). In this review paper, methodologies to 
transfer and harvest energy in implantable medical devices are introduced and discussed to 
highlight the uses and significances of various potential power sources. 
Keywords: implantable medical devices; energy harvesting; wireless power transfer; power 
management; inductive coupling 
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1. Introduction 
In the past few decades, we have witnessed tremendous development in electronics, micro- and  
nano-fabrication, and wireless technology which have greatly enhanced the quality and efficacy of healthcare 
as well as life-science research [1–4]. These innovations dovetailed with advanced biomaterials have enabled 
miniaturized sensors and biocompatible devices that could be implanted in vivo in humans and animal 
models, allowing diagnosis, prognosis and biological investigations [5–7]. Chronic diseases of inner organs 
have been elucidated in animal models, and/or diagnosed and treated in real patients with support from 
numerous implantable devices [6,8–11]. Recently, flexible and stretchable electronics has been  
introduced and demonstrated, showing promise for the future of healthcare, biological-science discoveries 
and medicine [2,7,12]. Unreachable locations in vertebrates’ bodies challenging scientists such as the deep 
brain, intravascular regions, inside the heart or even a location inside a single cell have been assessed and 
investigated with miniaturized implantable systems [13–16].  
Implantable Medical Devices (IMDs) to improve healthcare, aiding or delivering the functions of 
certain malfunctioning organs have been around for years. They have been utilized for diagnosis, prognosis 
and treatment. IMDs can be categorized as active and passive devices depending on whether they require 
a power source or not, respectively. Nowadays, a host of chronic diseases have been addressed using IMDs 
all over the body, from the brain, cochlea and retina to the heart, lungs, knee joints and even vessels, the 
esophagus and the bladder. According to statistics from a decade ago, there were about three million people 
around the world with pacemakers and each year 600,000 more pacemakers were being implanted. 
Besides, more than 60,000 people were treated with cochlear implants [17]. The numbers have been rapidly 
increasing in recent years due to the larger population and a better healthcare system. For example, more 
than 230,000 new pacemakers were implanted in the USA in 2009 [18]. These facts indicate that IMDs 
have become more and more popular in humans’ life. 
To ensure proper operation, most IMDs need to rely on a permanent and sufficient power supply, thus 
numerous power sources for IMD have been widely investigated in the last decades. Different power 
approaches can allow for the autonomous operation of IMDs by generating electrical power to replace 
or supplement existing battery power. The existing major challenges have been size limitations, 
inaccessibility, the need to work continuously and biocompatibility. 
Since the first medical implant, the pacemaker, was introduced in 1972 using batteries [19–23], 
various types of batteries have been developed and deployed for IMDs [24–33]. Among those,  
lithium-based (Li) batteries have been the most popular power source owing to their high volumetric 
energy density as well as comparatively compact sizes [28,34,35]. Further, they have a considerably 
durable longevity of 5 to 10 years, and thus are appropriate for long-term applications [36]. Besides,  
bio-fuel cells exploiting biocatalysts for generating electric power from renewable biodegradable 
materials such as glucose or amylum are also potential sources [30,35]. Enzyme-based biofuel cells are 
able to operate under mild conditions (20–40 °C and close to pH = 7.0) generating milliwatt level power. 
Making them suitable for the majority of IMDs such as pacemakers, cardiac defibrillators and drug 
delivery systems. One other type—nuclear batteries—which was also introduced in early 1970s, were 
utilized to extend the lifespan of IMDs for more than 10 years. Their operation is based on the carried 
energy emitted by the particles from radioisotopes [37]. However, they were discontinued in the 1980s 
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due to the potential risks and the conclusion from physicians that IMDs should be updated with new 
technologies at least once a decade [38]. 
Alternative solutions have been also proposed, investigated and developed, by which energy was 
generated and harvested from potential sources surrounding the implants. The aforementioned biofuel 
cells are great candidates since they can exploit glucose and oxygen which are abundant in the blood to 
generate energy [27,39–41]. Further, vertebrates’ bodies and their daily activities are great sources of 
energy through heating (body heat) and movements like breathing and motion, that could be exploited 
to power up IMDs replacing the traditional batteries. For instance, the maximum temperature difference 
between the inner parts and the skin is 8 °C, which is sufficient to generate a few hundred microwatts of 
electricity using thermoelectric generators [42–44]. On the other hand, piezoelectric generators have 
been employed to convert kinetic energy into electricity utilizing piezoelectric materials [45–47]. 
Although they are able to generate considerably higher power, on the order of milliwatts, piezoelectric 
generators usually require massive motion, and hence are not appropriate for most implant  
locations [48–50]. Electrostatic and electromagnetic mechanisms have been also used to harvest energy 
using body motions, however their size limitations and low generated power limits their use in practical 
in vivo applications [51–54]. 
Instead of exploiting potential sources generated by the host, energy could be supplied to IMDs by an 
external unit to either charge the battery or continuously power the batteryless implant. This may be 
accomplished optically, ultrasonically or electromagnetically. Optical-charging methods consist of a 
photovoltaic cell in the IMD which receives power from a laser diode usually operating in the  
near-infrared or infrared range [55]. Ultrasonic devices have attracted growing interest in recent years due 
to their comparative efficiency, compactness and immunity to electromagnetic radiation [56–60]. 
Nonetheless, inductive power transmission across the body tissue is currently the only viable solution to 
deliver sufficient power to various kinds of IMDs with miniaturized dimensions [61]. This method is based 
on a pair of antennas by which power could be transferred through a mutual inductive coupling link. 
Therefore, antenna design and orientation, working distance and frequency, as well as the designated 
power would be considered. The power ranges of all the methods and IMDs are summarized in Figure 1. 
 
Figure 1. Power ranges of methods and IMDs. The scale is not in the right ratio, it is only 
for a conceptual illustration. Batteries and charging methods can deliver high power; 
however, in practical scenarios, it depends on the location of IMD, the size of IMD as well 
as the tissue. 
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In this review paper, we introduce methods to power active IMDs and present insightful discussions 
about each method. Approaches are categorized into two main groups: (1) IMDs that work independently 
with or without a one-time battery, or sustainably; and (2) IMDs which could be either battery-based or 
batteryless, obtaining power transferred from an external unit. Figure 2 presents these two groups. An 
overview about ultimate goals of IMDs is presented in the Discussion section followed by in-depth 
discussions of the most popular method, namely inductive coupling. 
 
Figure 2. Approaches to power IMDs. 
2. Methods to Power IMDs 
2.1. Independent Systems 
The first battery was invented by Volta in 1796 and since then numerous types have been discovered 
and applied to diverse uses in human life [62]. In general, batteries store energy in the forms of chemical 
substances which can produce electricity. Batteries contain anodes, cathodes and electrolytes to allow 
ions to move thus forming currents. There are three categories of power capabilities used for battery 
performance (low rate, medium rate and high rate). Although the definition is not yet clear, low-rate 
batteries should be able to provide a constant current of 100 µA while high-rate ones can supply a pulse 
power of at least 5 W for 10 s. Thus, the gap could be filled with medium-rate batteries. Among IMDs, 
pacemakers use low currents, neuro-stimulators and drug pumps need medium-rate ones and implantable 
defibrillators/cardioverters (ICDs) require extremely high power as well as additional longevity [32]. 
2.1.1. Lithium Batteries 
Typically, Li batteries were developed and appeared in the forms of Li metal anodes with cathode 
systems including iodine (Li/I2) [2,6,24,63,64], manganese oxide (Li/MnO2) [7,12,65,66], carbon mono 
fluoride (Li/CFx) [67–70], silver vanadium oxide (Li/SVO) [71–73] or hybrid cathodes  
(Li/CFx-SVO) [29,32,64,74,75]. As reliable sources for long-term applications such as cochlear 
implants, pacemakers, cardiac defibrillators or drug delivery, these Li batteries have been widely 
employed to provide appropriate power levels ranging from microamperes to amperes, as demanded by 
different types of IMDs [26,29,32].  
Among those, Li/I2 batteries have been proved to be safer and more reliable than others for uses with 
implantable pacemakers, thus they have been utilized by most manufacturers during the last  
40 years [27]. Li/I2 batteries have a discharge voltage of up to 3.6 V, which is equal to three times the 
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voltage generated by Ni-based cells. Their energy density can reach 210 W·h/kg, which can power a 
cardiac pacemaker for several years. Further, it is usually easier to measure the remaining energy of Li/I2 
batteries than other Li-based batteries, thus providing enough time to change the battery for  
IMDs [27]. On the other hand, Li/SVO batteries have been employed majorly for ICDs in the last  
30 years owing to their high capacity of over 300 W·h/kg. The presence of metallic silver also drastically 
improves the electronic conductivity [76]. In the mid-range, the systems with cathodes of  
thionyl-chloride (Li/SOCl2) have been widely used for neuro-stimulators and drug pumps. 
The recent advances in material research have led to a new class of Li-based batteries, namely flexible 
Li or Li polymer batteries [77,78]. While its advantages in flexible electronics and wearable consuming 
devices are undoubted, further implementations for implants have been limited due to the remaining 
obstacles in size and questions related to potential toxicity. 
2.1.2. Bio-Fuel Cells 
In general, bio-fuel cells are devices that transform biochemical energy into electricity based on 
electrochemical reactions involving biochemical pathways [30]. The link between biology and electricity 
was first discovered by Galvani in his experiments with frogs’ legs in 1791. He found the muscles of 
dead frogs’ legs twitched when electrical sparks were applied. The concept of ‘fuel cell’ was 
demonstrated in 1839 when Grove fully reversed the electrolysis process of water. He was able to 
recombine oxygen and hydrogen to produce water and interestingly, an electrical current [79]. The 
development of microbial-fuel cells (MFC) was then pioneered by Potter in 1911 when he discovered 
that one could generate a current of 0.2–0.5 mA at 0.3–0.5 V when a platinum electrode was placed into 
cultures of E. coli [80]. This indicated the potential of using microorganisms to generate power. The 
demonstration was achieved in 1931 when Cohen implemented biofuel cells providing 2 mA of current 
and 35 V voltage [30,81]. In a fuel cell, there are oxidation and reduction reactions occurring at the 
anode and cathode, respectively. Electrons released by the oxidation travel to the cathode to form an 
electrical current via an external circuit [30]. At the same time, protons move to the cathode through a 
proton-selective exchange membrane (Figure 3) [27]. 
 
Figure 3. Schematic of a bio-fuel cell. 
Based on the catalyst used, bio-fuel cells can be classified into microbial fuel (MFC) or enzymatic 
bio-fuel (EBC) cells; whereas considering the pathway through which electrons move from anode to 
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cathode, we can distinguish between direct or non-direct cells [27,30]. For example, the fuel can come 
from glucose and oxygen in the blood following these reactions: 
At anode: C6H12O6 → C6H10O6 + 2H+ + 2e− 
At cathode: O2 + 4H+ + 4e− → 2H2O 
The interest in MFCs was triggered in 1960s owing to the USA space program during which possible 
powering technologies had been sought for a waste disposal system for space flights [30]. The 
application of MFCs for IMDs was first initiated in 1960s when cell-free enzyme-based fuel cells were 
used for implantable artificial hearts [30,82]. During the 1970s, EBCs using glucose as fuel and oxygen 
as oxidizer were investigated to provide power for IMDs [27,30] and since then, various approaches and 
modifications have been proposed to enhance the performance as well as to target specific  
applications [28]. In 2003, Mano and colleagues reported a miniaturized bio-fuel cell capable of 
operation while implanted in a grape. They were able to produce a power of 2.4 μW at 0.52 V which 
was very promising for the applications with compact implants [83]. 
Bio-fuel cells present several advantages including the use of existing recyclable materials in Nature, 
the moderate operating conditions for the reactions and the biocompatibility between bio-fuel cells and 
the human body [31]. Nevertheless, challenges still remain. Firstly, it is difficult to maintain the 
biocatalyst over a long period and surgical intervention is of course not a desired option. Secondly, the 
microwatt level of bio-fuel cells limits their use in a wide range of applications. Finally, even though 
they are highly biocompatible, unavoidable biofouling still occurs that can damage the device or harm 
the patients [27]. 
2.1.3. Nuclear Batteries 
In nuclear batteries, power is transformed to electricity through energy carried by particles emitted 
from radioisotopes. This process could be achieved in several ways. For instance, some utilize the 
electric potential difference produced by the particle emitted from the radioisotopes, some use the 
electric potential coming from the ionization of emitted particle bundles, others employ the 
photoelectrical conversion prompted by a fluorescent material, and the rest exploit the heat energy of 
radiation. The advantages of nuclear batteries lie in the fact that they can provide much longer service 
life (>15 years) than all other competitors, and their output energy is extremely stable, regardless of 
environmental factors (temperature, pressure and electric field). For example, the Betacel produced by 
Medtronics, Inc. (Minneapolis, MN, USA) with a volume of 1.8 mL, a height of 1.02 cm and a diameter 
of 1.52 cm, can provide 50 μW of power [27]. Further, their safety has been proved for as long as they 
are kept hermetic, however, the potential radioactivity danger as well as their expensive cost make them 
still unacceptable [32,33]. 
2.1.4. Thermoelectricity 
The thermoelectric effect could be exploited to obtain electrical energy using the temperature 
differences in the human body. Naturally, our body presents temperature differences between locations 
thus forming temperature gradients. When a temperature gradient is applied in a thermoelectric module, 
a potential difference appears across the material through the Seebeck effect (Figure 4a) [84]. Since the 
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human body is an unlimited heat-energy source, these generators’ lifetime is also naturally  
unlimited [85–88]. Nevertheless, the thermal gradients in the human body are relatively small, making 
it difficult to achieve significant power outputs. Since thermoelectric generators are a type of heat engine, 
their efficiency is proportional to the Carnot efficiency which is defined as [89]: 
ŋ௖ ൌ 1 െ ௖ܶ௛ܶ ൌ
௛ܶ െ ௖ܶ
௛ܶ
 (1)
where ŋc is the Carnot efficiency, Th and Tc represent the hot and cold temperatures in Kelvin, 
respectively. TEGs are normally made up of semiconductor materials, with the most common ones being 
bismuth telluride (Bi2Te3) and polycrystalline silicon-germanium (poly-SiGe) film [90]. A thermoelectric 
module is usually formed by n-doped and p-doped semiconductor thermocouples placed electrically in 
series and thermally in parallel. In 1999, Stark and Stordeur reported a 0.19 cm3 thermoelectric generator 
which could produce 1.5 µW and 5.8 µW at 5 K and 10 K of temperature gradient, respectively [91]. 
The device was fabricated by sputtering the thermoelectrically effective material Bi2Te3 on 75 µm thick 
Kapton (Dupont, Wilmington, DE, USA) substrates to obtain the thermopile structure. The final 
integration density was 11.9 thermocouples/mm3. Later in 2004s, Strasser et al. introduced their work in 
which micro-machined CMOS thermoelectric generators were developed using poly-SiGe material 
deposited on a polysilicon substrate. They obtained a power output of 1 µW with generators of 1 cm2 in 
size with respect to 5K in temperature gradient [92]. In fact, the maximum temperature difference 
between the inner part of the body and the skin surface is about 8 K, therefore, the maximum output 
power can be about 180 μW/cm2 [93]. Thus it can be seen that thermoelectric generators only provide 
sufficient power for IMDs which require low microwatt power. To increase the output power, a large 
number of thermocouples needs to be cascaded in a proper way but this would face the issues of size, 
reliability and biocompatibility [84]. 
(a) (b) 
Figure 4. Conceptual views of (a) thermoelectricity; and (b) piezoelectricity. 
2.1.5. Piezoelectricity 
The piezoelectric phenomenon was discovered in 1880 by the French physicists Jacques and Pierre  
Curie [94]. It could be verified that certain materials generate a proportional electrical polarization with 
respect to the applied mechanical stress via the piezoelectric effect. To date, numerous piezoelectric 
materials have been utilized to generate energy for various applications [95,96]. The physical phenomenon 
underlying here is based on the fact that the electrical charge accumulating in certain solid materials will 
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be induced when it is subject to mechanical deformation (Figure 4b). Therefore, piezoelectric transducers 
could exploit the mechanical energy produced by our body motions [45–47]. The human body motions 
can be classified into two categories: continuous motions such as human respiration and blood flow, and 
discontinuous motions such as walking and hand movement. Several groups have investigated the use of 
discontinuous human body motion for piezoelectric energy harvesting [97–99]. The piezoelectric 
transducer is integrated in moving locations such as joints, whole-body center mass motion, muscle 
twitches and into shoes [98,100–103]. The ankle, knee, hip, elbow, and shoulder motions can generate up 
to 69.8 W, 49.5 W, 39.2 W, 2.1 W, and 2.2 W, respectively [98]. On the other hand, the continuous motions 
obtained from blood flow or respiration can provide lower power compared with that of the piezoelectric 
power harvester using discontinuous motion. For example, the maximum power generated by a 
piezoelectric plate with a radius of 5.62 mm and a thickness of 28 μm in a blood-flow environment is  
0.33 μW [104]. Obviously, piezoelectric harvesters are good candidates to power implants, but they need 
significant movements to generate considerable power, thus the practical implantable locations are limited 
(i.e., knee, elbow, foot). For instance, efforts by Kymissis et al. in 1998 resulted in a 1 W of output power 
delivered by a piezoelectric transducer integrated in a shoe heel [46]. However, achieving and harvesting 
energy from such a system in vivo remain the most important questions to answer. Again, the small size 
and the biocompatibility issues are always the biggest challenges. 
2.1.6. Electrostatic Generators 
Electrostatic generators produce electricity via electrostatic induction which is based on the electrostatic 
potential energy as the result of conservative Coulomb forces [105]. They are designed to exploit 
mechanical motion to induce electrical energy as the moving parts of the transducer are under effect of an 
electric field. A common construction for electrostatic generators consists of two conductive plates that 
are electrically isolated via air, vacuum or a dielectric insulator (capacitor), and relatively mobile  
(Figure 5a) [53]. The distance between the two electrodes of the capacitor changes due to the movement 
or to the vibration of one movable electrode caused by the motion of human body.  
(a) (b) 
Figure 5. Conceptual views of (a) electrostatic; and (b) electromagnetic generators. 
There are two operation modes for an electrostatic energy harvester: constant charge mode and 
constant voltage mode [106]. The plates are charged via an external source such as a battery. Besides, 
there are three different types of electrostatic generators which can be defined according to their 
actuation direction: the in-plane gap closing, out-of-plane closing and in-plane overlap [107]. The  
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in-plane gap closing techniques offer the highest output power compared to other actuation techniques. 
Electrostatic generator harvesting systems can be built by silicon micromachining fabrication techniques 
and present good integration capabilities with microelectronic circuits and other technologies, thus 
standing out as good candidates for IMDs. Microelectromechanical systems-based (MEMS-based) 
technologies enable miniaturized size, making these generators implantable inside the human  
body [52,108]. Recently, several works on the use electrostatic power harvesting systems to power 
biomedical devices have been reported. For example, an electrostatic generator was reported to exploit 
ventricular motion and heartbeat to feed a cardiac pacemaker and could generate 36 μW and 58 μW, 
respectively [54,109]. Further, Meninger et al. developed an electrostatic generation system which could 
produce 8 µW of power using MEMS-based technology. In their work, Miao and colleagues 
implemented a non-resonant MEMS-based electrostatic generator, which could thus provide flexibility 
of operation with a wide range of excitation frequencies. They obtained 80 µW for operation at 30 Hz 
with respect to movement of 0.1 m/s [108]. Overall, the high output impedance and voltage of the 
electrostatic generators making them less suitable for power supply devices due to the reduced amounts 
of available current due to the high output voltage. In addition, the amount of energy produced is 
typically low and these generators usually need an additional voltage source to initially charge the 
capacitor, representing the major disadvantage of this technology. 
2.1.7. Electromagnetic Generators 
Electromagnetic generators harvest energy based on the Faraday–Neumann–Lenz law which states 
that the relative motion between a coil and a permanent magnet produces a time-variable magnetic flux 
and consequently generates a voltage. This can be done in two ways: (1) relative motion is utilized while 
the generating system is fixed; and (2) rigid body motion is used with the inertia force of a weight on 
the generator [110]. Typically, the power is produced through the relative movement of the magnet and 
coil, or due to the changes in the magnetic field [51,111]. Therefore, the amount of electricity generated 
can be a function of magnetic field strength, relative motion velocity and the number of turns of the coil. 
Like those approaches based on piezoelectric or electrostatic transducers, electromagnetic generators 
exploit human body motions to generate power (Figure 5b).  
The low-frequency and irregular movements of humans make electromagnetic techniques suitable for 
powering IMDs. For example, with the repeating contraction of the heart muscle at a frequency between 
0.5 and 2 Hz, a power of 40–200 μW could be generated [112,113]. Roberts et al. investigated an 
electromagnetic generator using MEMS technology to enhance the power for pacemaker batteries in 
clinical trials [114]. The abdomen moves with a frequency of 0.3 Hz during breathing, producing a power 
of about 1.1 mW through an electromagnetic generator with a volume of 16 cm3 [115]. Using human 
walking, an electromagnetic generator with a size of 2.6 mm2 could generate 400 μW [116]. High 
performance bulk magnets, multi-turn and macroscale coils are readily available; nevertheless, the main 
challenge of the MEMS fabrication technology utilized in this approach is the poor properties of planar 
magnets [51]. In addition, the electromagnetic generators produce lower power compared with that 
obtained by piezoelectric generators. 
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2.2. Systems with an External Unit 
While independent systems can provide solutions which bring comfort and avoid complexity, they 
showing their weaknesses in the areas of reliability, low output power (MFCs, thermoelectricity) as well 
as potential to cause toxicity and failing to deliver biocompatibility. Systems with external units to transfer 
energy continuously are therefore of interest with the increasing need of communication between IMDs 
and smart devices. The power can be sent through the body tissues optically, mechanically or 
electromagnetically, and these methods are presented and discussed in the following sections. 
2.2.1. Optical Charging 
Optical charging methods utilize a photovoltaic cell integrated in the implant. The power can be 
transmitted through a laser diode in the near-infrared (near-IR) or infrared region and received by an 
array consisting of photovoltaic cells [55,117]. Light typically has low interactivity with biological 
tissues. Depending on the wavelength, the radiation allows to access deep inside biological tissues. The 
photovoltaic-cell array converts the received radiation into a current to charge/operate the IMDs  
(Figure 6a).  
(a) (b) 
Figure 6. Conceptual views of: (a) optical charging method; and (b) ultrasonic transducer. 
The photovoltaic cell is composed of a p-n junction of a large-band-gap semiconductor. The junction is 
optically charged as incident photons form electron-hole pairs, enabling electron mobility. If a load is 
connected, free electrons will flow through the load and then go back to the cell, where the holes are  
located [118]. These devices can generate power on the order of hundreds of microwatts. The photovoltaic 
cell array with surface area of 2.1 cm2 charged by a power density of 22 mW/cm for 17 min can generate 
a 20 μA current, which is sufficient for a pacemaker to operate for 24 h [119]. Using this approach, not 
only power, but information data can also be transferred using the optical link [120]. Nevertheless, during 
the charging period, the laser irradiation could raise the skin temperature by 1.4 °C, which may cause side 
effects [121]. In addition, this method remains several drawbacks, such as large size and low efficiency. 
2.2.2. Ultrasonic Transducer 
This technology has received growing interest in the past years [56–59] due to its advantages 
compared with other technologies in efficiency, size and immunity to electromagnetic radiation from 
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other devices [60]. The ultrasonic transducer is excited mechanically by an external ultrasound source 
using an ultrasonic transducer which can operate through capacitance mode or piezoelectric  
mode [122,123]. The implanted ultrasonic generator produces power from a received acoustic wave 
transmitted by an external unit. The incident acoustic wave is converted to electrical voltage through the 
capacitance change or the piezoelectric effect in cases of capacitive ultrasonic transducer (CUT) or 
piezoelectric ultrasonic transducer (PUT), respectively (Figure 6b). An ultrasonic power harvesting 
system can be fabricated using MEMS technology, therefore, the compactness makes them suitable for 
IMDs. However, the high voltage requirement makes CUTs unsuitable for in vivo operations. On the 
other hand, PUTs are promising as they utilize piezoelectric materials to convert the received acoustic 
waves into power. In 1988, Cochran et al. reported the first implanted ultrasonic power source which 
operated with an input voltage of 10–20 V at a frequency of 2.25 MHz of the external ultrasound source 
to excite a 5 × 5 × 0.9 mm3 piezo-ceramic transducer. The device could generate an output power of  
1.5 mW/cm2 [124]. Besides transferring power, a ultrasonic system can be used to send data to an  
IMD [125]. Further, a piezo-ceramic transducer with a diameter of 3.5 mm implanted inside living 
tissues and excited by an external circular transmitter (12 mm diameter) at a frequency of 2.25 MHz was 
able to generate an output power up to 1.5 m·W/cm2 capable of driving a peripheral nerve  
micro-stimulator [126]. In general, the major advantage of this approach is the ease of choosing the 
operating wavelength. The long-wavelength ultrasounds can penetrate deeper into the human body but 
cover an undesirable area, contrariwise the short-wavelength waves can focus on the desirable area but 
they cannot penetrate the desirable depth [127]. Despite these advantages, ultrasonic power transfer still 
faces many challenges. In general, using ultrasonic power is considered safe and effective, but there have 
been some cases in which physical pain due to cavitation described as a burning feeling, was caused by 
the heating of the gas contained in tissue cell nuclei. This would lead to difficulty in breathing, dizziness, 
nausea and disorientation [127]. 
2.2.3. Inductive Coupling 
It has been more than 180 years since Michael Faraday figured out power could be transferred through 
the air by magnetic induction. In 1914, wireless power and data transfer based on the magnetic coupling 
of two loops were initially reported by Tesla [128]. Recently, especially during the last decade, inductive 
coupling has been widely investigated to power up IMDs. The principle behind is based on a mutual 
inductance between two coils in which one is located outside the body while the other is integrated with 
the implanted device. As the external antenna transmits a varying electromagnetic signal, a voltage 
would be induced in the receiver coil (Figure 7). The wireless power efficiency depends on the resonance 
frequency (or operating frequency), distance, alignment, and coupling matching between the transmitter 
and the receiver coils [5,6,129–132]. In addition, the inductive technology can be exploited to 
transmitted data from outside to inside the body and vice-versa without using a radio-frequency (RF) 
transmitter or receiver with data rates up to few hundreds kilobits per second [5,6,121,133].  
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Figure 7. Inductive coupling overview.  
In their work, Parramon et al. developed an inductive coupling power source which could generate 19 
mW at a carrier frequency of 10 MHz. This was used to power a microsystem for electromyography (EMG) 
recording implanted in rabbit muscle. The diameter of the inside coil, the diameter of the outside coil, and 
the distance between the two coil were 10 mm, 20 mm and 15 mm, respectively [134]. Another example 
was the use inductive coupling to power a wireless camera capsule for non-invasive visual inspection of 
the small bowel at a carrier frequency of 1 MHz [20]. This power source could generate up to 150 mW 
and the distance between the two coils was 205 mm. The size of the inside coil was  
10 × 13 mm2. In 2004, Catrysse et al. presented an inductive link power source system which could deliver 
50 mW over a 3 cm distance operating at 700 kHz in bench-top experiments [135]. Further,  
in 2007, Ghovanloo and Najafi demonstrated a system-on-chip (SOC) by combining application-specific 
integrated circuit (ASIC) design with off-chip components (LC tank; filters) delivering 50 mW over a  
5 mm distance at 5/10 MHz frequency [136].  
There are several essential factors in inductive coupling approach, such as misalignment, size of the 
implant antenna, unknown side effects and the limited carrier frequency due to tissue absorptions, thus  
low-megahertz ranges (0.3–30 MHz) have been widely used [5]. For further information about this approach, 
readers should refer to the Discussion section where inductive coupling is thoroughly discussed. 
3. Discussion 
3.1. Implantable Medical Devices: Roles and Future Expectations 
With the rapid development of advanced technologies in the last decade, healthcare has been changed 
in several aspects. Nano- and wireless-technologies have transformed medical diagnosis, monitoring, 
and intervention into individualized care [6,137,138]. Definitions of self-care, e-care, mobile-health and 
the Internet of Things (IoTs) have emerged, changing the traditional roles of doctors and patients. People 
are capable of monitoring their health every day with innovative devices while large scale medical data 
could be assessed and diagnosed continuously by caregivers located thousands miles away. In many 
cases, the devices need to be inserted to stay safely and securely in the body for a period of time; thus a 
new expectation is raised for IMDs that the implant needs to be able to communicate with external units 
for real-time tracking and sensing, diagnosis and treatment. In order to achieve that, a sufficient power 
source becomes mandatory, no matter whether the device is active or passive. 
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In this upcoming scenario, power is needed not only for running the implant but also for feeding the  
high-consuming wireless communication, and this would concurrently drain out the battery of the implant 
and consequently reduce the lifetime of the device. A conceptual view of a future IMD is sketched in  
Figure 8. With these expectations, an IMD (1) can be powered from an external unit, such as a wearable  
belt (4) if the IMD is located in the abdomen or a hat (2) if the IMD is in the brain/head location. If there is a 
subcutaneous IMD in the arm/hand location, it can be powered by a wrist device (3). For wireless 
communications, IMDs can directly send data to a smartphone or via external units. Algorithms may be 
applied to filter, interpret and sort the data for diagnoses, storage or real-time examinations by distanced  
care-givers. Big data processes and mobile cloud systems will be needed to facilitate the infrastructure. We 
envision this will be the model of healthcare in the future which can significantly save time, and cost, 
providing efficiency and efficacy for our society. Obviously, in that dream picture, reliable micro-sensors 
and communication, durable power and systems as well as smart algorithms and designs, are essential. Other 
issues such as safety, usefulness, fashion and comfort also need to be improved in order to bring cutting-edge 
devices not only to patients but also the general public. 
 
Figure 8. Overview of IMDs and other components. (1) Implant; (2–4) External devices. 
3.2. IMDs Power Source Approaches: Advantages and Limitations 
Although there are challenges and issues that remain unsolved, IMDs have been useful and popular in 
healthcare applications such as medical monitoring and diagnostics. For example, a survey taken in 2009 
involving 1,002,664 pacemakers and 328,027 ICDs, including new implants and replacements, found that 
the U.S. had the largest numbers, with 264,824 and 133,262 for pacemakers and ICDs, respectively [18]. 
In most cases, IMDs used non-regenerative power sources, namely batteries. To date, when safety is 
ensured with proper packaging, batteries still appear to be the most reliable power supply for IMDs when 
size, functionality and operation time are compromised. Compared with batteries, the most common issue 
for independent systems such as bio-fuel cells and thermoelectricity, is the low-output power while 
wireless powering systems add complications causing discomfort and none of the possible approaches 
could provide a reliability level which can be accepted in the stringent medical world.  
However, sustainable sources to power chronic or life-time IMDs are still of high interest. There is 
another set of cases in which it is hard to access the implanted location (e.g., intravascular applications) and 
thus a biodegradable implant is favorable. Recent endeavors producing innovative biomaterials [139,140] 
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have enabled the realization of those, but a batteryless solution for power using degradable materials needs 
to be defined. Table 1 briefly summarizes the different advantages, disadvantages, and power generation of 
power approaches for IMD applications. 
Table 1. Power approaches for IMD applications. 
Energy Harvesting Method Approaches Generated Power References Advantages Disadvantages 
Independent system 
Lithium batteries 
210 W·h/kg [27] Compatibility with 
flexible electronic 
Size 
300 W·h/kg [76] Toxicity 
Bio-fuel cells 2.4 μW [83] 
Recycle materials Lifetime 
Biocompatibility with 
human body 
Low output power 
Nuclear batteries 50 μW [27] 
Longer service life  
(>15 years) 
Radioactive danger 
Stable output energy Expensive 
Thermoelectricity 
5.8 µW [91] 
Unlimited lifetime Low output power 1 µW [92] 
180 μW/cm2 [93] 
Piezoelectricity 
2.1–69.8 W [98]  High output power Limited implantable locations 
0.33 μW [104] No additional voltage 
source 
Biocompatibility issues 
1 W [46] 
Electrostatic 
36 μW [54,109] 
High output power 
Additional voltage source 
58 μW [54,109] 
High output impedance 
80 µW [108] 
Electromagnetic 
40–200 μW [112,113] 
Unlimited implantable 
locations 
Complexity in fabrication 
technologies 
1.1 mW [115] 
400 μW [116] 
Systems with external unit 
Optical charging 22 mW/cm [119] High output power Large dimension 
Ultrasonic 
transducer 
1.5 mW/cm2 [124,126] 
Data transfer Low output power 
May be used for 
different depths 
Side effects 
Inductive 
coupling 
19 mW [134] High data rate and 
power transmission 
Limited carrier frequency  
due to tissue absorptions 150 mW [20] 
50 mW [135,136] 
No batteries needed Side effects 
6.15 mW [141] 
In an expected regular IMD of the coming era, the time of m-Health and IoTs, there will be pivotal 
components which are highly-sensitive biosensors, low-power integrated electronic circuits,  
low-power and reliable wireless communication, and obviously a sufficient power source. While the 
recent advances in nanotechnology and materials [2] have enabled the realization of smaller and more 
sensitive sensors consuming less energy as well as low-power and more compact electronics, the 
increasing need for communication and interaction with other devices and a mobile cloud requires much 
higher power to operate the new-generation devices. As a result, a catch-22 without an absolute solution 
yet is faced. Although tremendous effort has been spent by scientists in order to investigate approaches 
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to either exploit human energy or remotely transfer the power, the proposed solutions still cannot provide 
enough energy to operate smaller-and-smaller devices with more-and-more functionalities. An 
illustration of a pacemaker with more than 80% of volume reserved for the battery has been a real 
obsession and challenge for scientists working in the field, not to mention the recent call for wireless 
communication for m-Health applications. 
Recently, numerous novel bio-sensing mechanisms using DNA [142–144] have been proposed 
implying that hybrid systems in which electronics and biological elements are merged will be possible 
in the coming years. Such systems would definitely require very low power but bring the highest level 
of sensitivity and biocompatibility as they would not be treated as foreign objects in our biological 
environment, not to mention minimizing biofoulings and inflammatory responses. However, as wireless 
data communication is still a necessity, the challenging power issue remains unsolved. Although a large 
number of low-power and more-effective wireless communication methodologies and protocols have 
been invented recently, the mechanism has remained unchanged, with wireless chips, regular 
amplification circuits, filters, and converters dealing with electromagnetic waves at some frequency. 
This would always overwhelm a compact IMD.  
Besides IMDs for uses in humans, implantable devices have been widely used with animal models 
for biological investigations and drug screening. While the safety issues are not comparable with those 
of devices used for humans, most of the animal models (i.e., mice, zebrafish, and rats) present more 
challenges due to their much smaller size. Consequently, the lessons taught by overcoming the obstacles 
in animal models can be translated to IMDs. For instance, the recent effort in providing a wireless 
electrocardiogram (ECG) monitoring system to elucidate heart regeneration in zebrafish and neonatal 
mice [145,146] could suggest a solution for implantable devices used with humans, in which power is 
inductively transferred while data is sent optically. 
3.3. Inductive Coupling: Possibilities and Challenges 
Wireless powering via a resonance-based inductive link has been extensively investigated for a wide 
range of applications in the recent years owing to the capability to provide sufficient power, the reliability 
and the possibility to integrate it with other electronic components. Further, the inductive link could also 
be exploited for data transmission [5,6,136]. In the domain of medical devices, numerous approaches were 
proposed with innovations in design, materials and circuits in order to target specific applications. For 
IMDs, the operating frequencies are usually in the low MHz or KHz range to minimize the power absorbed 
by the tissue which may cause tissue heating and side effects [6,135]. A number of studies have been 
carried out to improve the power transfer efficiency (PTE) of regular 2-coil systems [20,23,34,147–149], 
in which coil geometry, coil dimensions, number of turns, and coil losses were examined for optimization. 
Recently, MEMS technology and advanced materials have enabled the fabrication of miniaturized coils 
on either flexible or hard substrates, which could be integrated monolithically with other electronic 
components. While the problem of a smaller coil resulting in less coupled energy remains unsolved, we 
also face with another challenge that the thin fabricated metal film of the coil (usually <1 µm) would cause 
an extremely low quality factor (Q), and consequently low PTE. Our group recently proposed a solution 
using the low-temperature co-fired ceramic (LTCC) technology to cascade the spiral coils in multiple 
layers (up to 10 layers in LTCC) to improve PTE (results to be published). Utilizing LTCC, improvement 
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was achieved not only from the higher number of turns by cascading but also from the thick metal layer 
(>8 µm) resulting in higher Qs. Although LTCC could bring enhance PTE as well as the capability of 
integration with electronics as well as lab-on-a-chip applications, the hard material and the high processing 
temperature restrict the use with numerous IMDs. 
In practical scenarios, most anatomical surfaces are highly curved and most organs are relatively 
mobile during daily activities, requiring IMDs to be flexible and to remain functional. However, the 
inductance of the flexible coil antenna would change with respect to mechanical environmental cues, thus 
varying the resonance frequency of the LC tank in the IMD. If the changes are significant, the PTE would 
be reduced drastically. This calls for the implementation of an adaptive mechanism to ensure the resonant 
frequencies are matched on both sides [149–151]. However, this may add components to the room-limited 
IMDs. Another practical issue is misalignment which has been widely investigated [5,35,152]. For specific 
IMDs attached to moving organs such as the stomach, positional and angular misalignment becomes 
critical. Recent investigations have shown the superiority of spiral structures for transmitter antennas to 
produce a large-cover beam size, minimizing misalignment issues [153]. Nonetheless, misalignment is 
case-dependent and unavoidable, requiring thorough calibration and investigation in a simulated 
environment before actual use. 
Instead of using a conventional 2-antenna system, multi-input and multi-output (MIMO) systems have 
been investigated [154–156]. Obviously, as the field is continuously active, multiple IMDs can be used 
simultaneously, however it would lead to a complicated case as it affects the mutual inductance between any 
two antennas and consequently, the PTE. Further, it is also difficult to place a ‘repeater’ to improve the PTE 
and distance, as mentioned in [157]. The most possible case that could help is using multiple transmitters 
with one receiver in an IMD [156]. For example, two or more transmitters can be located around the torso to 
increase the power sent to IMDs. Nevertheless, it would be hard to obtain constructive superposition and 
field optimization in dynamic cases with the inevitable daily activities of users. 
It would be improper to not mention the biological effects caused in tissues by the electromagnetic 
field [41,158]. Although it has been studied, attention was paid mostly to the acute effects generated by 
heating, while long-term health issues are concerns preventing patients and the public from accepting 
and using IMDs with inductive coupling.  
4. Conclusions 
The limited lifespan and biocompatibility are the most serious issues with all power approaches used 
in IMDs. Alternative methods have been investigated extensively to replace existing conventional 
battery-based systems for powering IMDs. Towards this end, this review addresses a dual goal:  
(1) summarize various key power approaches for IMDs and highlight the strength and weakness of each 
one; (2) raise concerns and discuss trends in IMDs towards future medicine and healthcare applications. 
All approaches for harvesting energy with independent systems and with an external unit are reviewed 
and discussed. The independent system approach used the body environment energy such as body 
temperature and body motion to generate the electrical energy to power the IMDs. These approaches are 
based on thermoelectric, piezoelectric, electromagnetic and electrostatic effects, providing unlimited 
lifetime, but the low output power and the limited implant location choices represent the major 
challenges. On the other hand, the power approaches using an external unit such as optical charging, 
ultrasonic transducer and inductive coupling allow transferring the power and information data as well 
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as enable the ability to power the IMD in different body locations. Democritus once stated: “Everything 
existing in the universe is the fruit of chance and necessity”. Taking this message, we’ve fully 
understood the importance and significance of each approach to power IMD and highly appreciated 
invaluable contributions of scientists on the road towards a better life of our society.  
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